Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,113
Closed -$148K 3161
2026
Q1
$148K Hold
10,113
﹤0.01% 2684
2025
Q4
$128K Sell
10,113
-16,052
-61% -$237K ﹤0.01% 2762
2025
Q3
$397K Sell
26,165
-35,612
-58% -$574K ﹤0.01% 2213
2025
Q2
$984K Buy
61,777
+35,569
+136% +$539K ﹤0.01% 1811
2025
Q1
$496K Sell
26,208
-689
-3% -$15.1K ﹤0.01% 2086
2024
Q4
$648K Buy
26,897
+3,719
+16% +$104K ﹤0.01% 2024
2024
Q3
$647K Buy
23,178
+2,419
+12% +$68.3K ﹤0.01% 1886
2024
Q2
$538K Sell
20,759
-201
-1% -$4.18K ﹤0.01% 1938
2024
Q1
$458K Buy
+20,960
New +$449K ﹤0.01% 2144
2023
Q2
Sell
-78,472
Closed -$1.54M 2716
2023
Q1
$1.54M Buy
78,472
+59,764
+319% +$1.15M ﹤0.01% 1606
2022
Q4
$322K Buy
+18,708
New +$332K ﹤0.01% 2501

Other funds holding RXO

HSBC Holdings's RXO Position: Q2 2026 in Review

HSBC Holdings sold out of RXO (RXO) in Q2 2026, closing a stake of 10,113 shares — an estimated $148K sold.

HSBC Holdings first reported a position in RXO in Q4 2022 and held it in 11 quarters. The position peaked at $1.54M in Q1 2023. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • HSBC Holdings reported no remaining RXO position as of Q2 2026 after selling out during the quarter.
  • HSBC Holdings sold 10,113 RXO shares in Q2 2026, an estimated $148K.
  • HSBC Holdings first reported a position in RXO in Q4 2022 and held it in 11 quarters.
  • HSBC Holdings's RXO position peaked at $1.54M in Q1 2023.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.